Evidence map›Paper›PMID 27468334›Full record

ReviewWorld journal of cardiology2016

Takotsubo syndrome: Advances in the understanding and management of an enigmatic stress cardiomyopathy.

Hernán David Mejía-Rentería, Iván J Núñez-Gil

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cannabis-induced basal-mid-left ventricular stress cardiomyopathy: A case report.International journal of critical illness and injury science · 2020
    Article
  8. Review
  9. Article
  10. Article
  11. Impact of ST-segment elevation on the outcome of Takotsubo syndrome.Therapeutics and clinical risk management · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Hernán David Mejía-RenteríaHernán David Mejía-Rentería, Servicio de Cardiología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, 28805 Madrid, Spain.
Iván J Núñez-GilHernán David Mejía-Rentería, Servicio de Cardiología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, 28805 Madrid, Spain.
Creative Research Enterprises (United States) · USHospital Clínico San Carlos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Takotsubo cardiomyopathy is a syndrome mimicking an acute myocardial infarction in absence of obstructive epicardial coronary artery disease to explain the degree of the wall motion abnormalities. Typically more common in the elderly women, this condition is usually triggered by unexpected emotional or physical stress situations, and is associated with electrocardiogram abnormalities and slight elevation of cardiac biomarkers. The pathophysiological mechanism is not clear yet, but it is believed that a high circulating concentration of catecholamines causes an acute dysfunction of the coronary microcirculation and metabolism of cardiomyocytes, leading to a transient myocardial stunning. Typically, it presents with acute left ventricular systolic dysfunction that in most cases is completely resolved at short term. Recurrences are rare and it is thought that the long-term prognosis is good. We present here a review of the clinical features, pathophysiology and management of this enigmatic condition.

Indexed as

Left ventricle systolic dysfunctionMyocardial stunningReviewStressTakotsubo cardiomyopathy

Identifiers

PMID27468334
PMCPMC4958692
OpenAlexW2479573265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.